Toronto, Ontario–(Newsfile Corp. – April 15, 2025) – Specialty Medical Partners, We aim to establish Canada’s most comprehensive outpatient specialty medical group, integrating all aspects of non-hospital-based specialty care., will be participating in the 2025 Bloom Burton & Co. Healthcare Investor Conference, which will take place on May 5 and 6 at the Metro Toronto Convention Centre.
| Dates: | Monday May 5, 2025 – Tuesday May 6, 2025 |
| Time: | 8:30 AM – 5:00 PM ET |
| Location: | Metro Toronto Convention Centre, North Building 255 Front St W Toronto, Ontario M5V 2W6 |
Michael Black, CEO will be speaking at 3:00 PM ET ON Tuesday, May 6th. Interested parties can register to attend the conference here.
Members of Specialty Medical Partners management will also be taking meetings from interested investors throughout the day. Take advantage of the opportunity and reach out to the team.
To register for the conference, please follow this link.
About Specialty Medical Partners
At Specialty Medical Partners, our mission is to deliver exceptional medical care through close collaboration with our practice partners and a deep commitment to serving our patients and communities. We strive to create a personalized, compassionate healthcare experience that prioritizes patient well-being and fosters a sense of connection, trust, and shared ownership among our team members.
About the Conference:
The Bloom Burton & Co. Healthcare Investor Conference brings together U.S., Canadian and international investors who are interested in the latest developments in the Canadian healthcare sector. Attendees will have an opportunity to obtain corporate updates from the premier Canadian publicly traded and private companies through presentations and private meetings.
About Bloom Burton & Co.:
Bloom Burton & Co. is a firm dedicated to accelerating returns in the healthcare sector for both investors and companies. Bloom Burton has an experienced team of medical, scientific, industry and capital markets professionals who perform a deep level of diligence, which combined with our creative and entrepreneurial approach, assists our clients in achieving the right monetization events. Bloom Burton and its affiliates provide capital raising, M&A advisory, equity research, strategic advisory, as well as company creation and incubation services. Bloom Burton Securities Inc. is a member of the Canadian Investment Regulatory Organization (CIRO) and is also a member of the Canadian Investor Protection Fund (CIPF).
For questions and further information please contact:
Specialty Medical Partners
Michael Black
CEO
506 866-9806
info@specialtymedicalpartners.com
https://www.specialtymedicalpartners.com/
The DEA was created to combat cartel trafficking, protect public health, and ensure researchers have…
CAMBRIDGE, Mass., Dec. 07, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology…
Longer-term analyses reinforce duvelisib’s activity across treatment-experienced PTCL populations, including patients with ≥3 prior lines…
- Combination of evorpacept plus rituximab and lenalidomide (R2) generated complete responses (CR) in 92%…
Media ReleaseCOPENHAGEN, Denmark; December 7, 2025 Trial demonstrated treatment with fixed duration EPKINLY plus rituximab…
― Clear dose-response observed, with a robust and clinically meaningful fetal hemoglobin (HbF) induction at…